The TME analysis on day 9 after implantation demonstrated that Ptger4-overexpressing mammary tumors had significantly reduced counts of immune cells compared with the controls (Supplemental Figure 7F), confirming the role of tumor cell–intrinsic EP4 signaling in suppressing antitumor immunity and promoting tumor growth. Here, PTGER4 is linked to breast cancer.